Press Releases

The Summit will bring together industry leaders, university researchers and venture capitalists to facilitate networking and business partnerships this October 10-12 at the Westin Bayshore in Vancouver, Canada.

BIO Investor Forum will be held October 9-10, 2012 in San Francisco, CA 

The Renewable Fuel Standard (FRS) sets a path for U.S. energy security, reduced reliance on foreign oil and a cleaner environment; and it’s working. 

Event to take place in Shanghai, China, October 24-25, 2012 .

Producing renewable chemicals and biobased products using homegrown biotechnology can generate additional employment opportunities across the United States, the Biotechnology Industry Organization (BIO) and its member companies said today. 

The global event for biotech will take place in Chicago, IL, April 22-25, 2013.

The House Subcommittee on Capital Markets held a hearing entitled “The 10th Anniversary of the Sarbanes-Oxley Act.” Jeff Hatfield, President and CEO of Vitae Pharmaceuticals, presented testimony about the effects of regulatory burdens in Sarbanes-Oxley.

New bill will update SEC filing status classifications to ease costly regulatory burdens on small public companies 

The Biotechnology Industry Organization (BIO) applauds the U.S. Navy’s operational debut of drop-in advanced biofuels in its ships and aircrafts this week at the 22-nation Pacific Rim training exercises off the coast of Hawaii. 

“The BIO Livestock Summit will focus on how we could use animal biotechnology to develop novel health care applications, provide more sustainable food animals and raise livestock that are more environmentally friendly.” 

BIO applauds the Department of Defense’s announced public-private partnership opportunity to support an integrated domestic advanced drop-in biofuel biorefinery and feedstock supply chains to provide the U.S. military with pre-certified blends of biofuels. 

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. Senate.